Dr. Kylie Ainslie

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	16552	16340
h-endeksi	35	33
i10-endeksi	68	66

5000

2500

1250

3750

2020202120222023202420254252 4930 3416 2141 1350 145

Genel erişim

Tümünü görüntüle

68 makale

1 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Steven RileyImperial College Londonimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Christl DonnellyProfessor of Applied Statistics, University of Oxfordstats.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Graham CookeImperial Collegeimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Ara DarziProfessor of Surgeryimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Helen WardProfessor of Public Health, Imperial Collegeimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Paul ElliottProfessor of Epidemiology and Public Health, Imperial College Londonimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Deborah AshbyProfessor of Medical Statistics and Clinical Trials imperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Oliver EalesUniversity of Melbourneunimelb.edu.au üzerinde doğrulanmış e-posta adresine sahip
Peter J. DiggleDistinguished Professor, Lancaster Universitylancaster.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Claudio FronterreLecturer in Biostatistics (Global Health)lancaster.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Charles WhittakerImperial College Londonimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
H Juliette T UnwinLecturer in Statistical Science, University of Bristolbristol.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Swapnil MishraAssistant Professor at National University of Singaporenus.edu.sg üzerinde doğrulanmış e-posta adresine sahip
Thomas A. MellanProtocol Labsprotocol.ai üzerinde doğrulanmış e-posta adresine sahip
Marc BaguelinSenior Lecturer, Imperial College London - Assoc. Prof London School of Hygiene & Tropical Medicineimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Seth Flaxmanassociate professor at Oxfordcs.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Axel GandyImperial College Londonimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Zulma M. CucunubáDirector, Instituto de Salud Pública, Pontificia Universidad Javeriana Colombiajaveriana.edu.co üzerinde doğrulanmış e-posta adresine sahip
K.A.M. GaythorpeImperial College Londonimperial.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Walter Orensteinemory.edu üzerinde doğrulanmış e-posta adresine sahip

Takip et

Dr. Kylie Ainslie

Dutch National Institute for Public Health and the Environment (RIVM)

rivm.nl üzerinde doğrulanmış e-posta adresine sahip

epidemiology infectious disease modelling vaccine effectiveness biostatistics


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College London, 2020	5153	2020
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ... Nature 584 (7820), 257-261, 2020	4279*	2020
The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries PGT Walker, C Whittaker, OJ Watson, M Baguelin, P Winskill, A Hamlet, ... Science 369 (6502), 413-422, 2020	1001	2020
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study AB Hogan, BL Jewell, E Sherrard-Smith, JF Vesga, OJ Watson, ... The Lancet global health 8 (9), e1132-e1141, 2020	904	2020
The global impact of COVID-19 and strategies for mitigation and suppression PGT Walker, C Whittaker, O Watson, M Baguelin, KEC Ainslie, S Bhatia, ... Imperial College London 26, 1-19, 2020	708	2020
Reduction in mobility and COVID-19 transmission P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ... Nature communications 12 (1), 1-9, 2021	624	2021
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College COVID-19 Response Team 20 (10.25561), 77482, 2020	399	2020
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ... The Lancet Infectious Diseases 20 (12), 1381-1389, 2020	223	2020
Response to COVID-19 in South Korea and implications for lifting stringent interventions A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ... BMC medicine 18, 1-12, 2020	215	2020
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, ... Nature communications 12 (1), 905, 2021	201	2021
State-level tracking of COVID-19 in the United States HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ... Nature communications 11 (1), 6189, 2020	190	2020
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment KEC Ainslie, CE Walters, H Fu, S Bhatia, H Wang, X Xi, M Baguelin, ... Wellcome Open Research 5, 2020	151	2020
Report 21: Estimating COVID-19 cases and reproduction number in Brazil TA Mellan, HH Hoeltgebaum, S Mishra, C Whittaker, RP Schnekenberg, ...	145	2020
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults H Ward, G Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ... MedRxiv, 2020.10. 26.20219725, 2020	142	2020
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021	135	2021
Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults H Ward, CJ Atchison, M Whitaker, KEC Ainslie, J Elliott, LC Okell, R Redd, ...	135	2020
Resurgence of SARS-CoV-2: detection by community viral surveillance S Riley, KEC Ainslie, O Eales, CE Walters, H Wang, C Atchison, ... Science 372 (6545), 990-995, 2021	116	2021
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College London, 2020 NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Publish in The International Arabic Journal of Antimicrobial Agents, 2020	106	2020
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults H Ward, GS Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ... The Lancet Regional Health–Europe 4, 2021	90	2021
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B. 1.617. 2), the Netherlands, August to September 2021 B de Gier, S Andeweg, JA Backer, SJM Hahné, S van den Hof, ... Eurosurveillance 26 (44), 2100977, 2021	85	2021

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar